RT Journal Article
SR Electronic
T1 Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e008975
DO 10.1136/jitc-2024-008975
VO 12
IS 7
A1 Bharadwaj, Sushma
A1 Lau, Eric
A1 Hamilton, Mark P
A1 Goyal, Anmol
A1 Srinagesh, Hrishi
A1 Jensen, Alexandria
A1 Lee, Dasom
A1 Mallampet, Jayasindhu
A1 Elkordy, Sarah
A1 Syal, Shriya
A1 Patil, Sunita
A1 Latchford, Theresa
A1 Sahaf, Bita
A1 Arai, Sally
A1 Johnston, Laura J
A1 Lowsky, Robert
A1 Negrin, Robert
A1 Rezvani, Andrew R
A1 Shizuru, Judith
A1 Meyer, Everett H
A1 Shiraz, Parveen
A1 Mikkilineni, Lekha
A1 Weng, Wen-Kai
A1 Smith, Melody
A1 Sidana, Surbhi
A1 Muffly, Lori
A1 Maecker, Holden T
A1 Frank, Matthew J
A1 Mackall, Crystal
A1 Miklos, David
A1 Dahiya, Saurabh
YR 2024
UL http://jitc.bmj.com/content/12/7/e008975.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.